Fourteen Months of Pain, an Irreversible Operation, and a Drug Class Nobody's Tried Yet
His workup is negative, NSAIDs haven't helped, and surgery is on the table. The disagreement is whether a mechanistically different oral option deserves a real trial before anyone reaches for an operation that can't be undone.
B.R., 38, supervises a warehouse floor, a job that keeps him on his feet and lifting for most of a ten-hour shift. Fourteen months ago he began noticing a dull, constant ache in his left testicle with no clear trigger, and it has not let up since, worsening by his own report toward the end of long shifts. A full workup — scrotal ultrasound, urology exam, infectious screening, and a careful check for varicocele or hernia — has come back entirely negative. He was diagnosed with idiopathic chronic orchialgia and tried a several-week course of NSAIDs, which provided minimal relief.
He has no other significant medical history, takes no regular medications, and describes the pain as constant rather than intermittent, which is part of what has made it difficult to work around rather than simply tolerate — an intermittent ache might be manageable around a shift schedule, but a constant one has meant modifying how he stands, lifts, and moves for most of his workday for over a year now. He has been referred for consideration of a diagnostic spermatic cord block, with microsurgical denervation of the spermatic cord raised as the eventual option if medical management continues to fail. Strom and Levine's single-center series reported complete durable relief in 71% of testicular units, but in men whose pain had run a mean of about five years before surgery; at fourteen months he is early against that population, with more room left for a reversible option than their patients had. The same series, and Benson's later work, admitted only men who had already responded to a cord block — which makes the block the thing that would place him inside that 71%, not the operation. He has never had a prior surgery of any kind, and the prospect of one, even a minor one, is clearly weighing on him more than the pain itself has so far — he has said outright that he'd rather try "one more thing that isn't a knife" first.
Whether one failed drug class rules out the others
None of the medical options here have real disease-specific trial evidence — they're all extrapolated from other chronic pain conditions. Denervation has the most concrete outcome data specifically for this problem, and he's already tried the drug class most commonly reached for. I'd move toward a diagnostic block and likely denervation rather than cycle through more unproven oral agents.
I'd push back on treating the NSAID failure as evidence against the whole medical route. NSAIDs target inflammation; a gabapentinoid or TCA targets a neuropathic pain mechanism entirely. Failing one says nothing about the other. An irreversible operation, with a real risk of ongoing pain or new numbness if it doesn't work, shouldn't be reached for before a mechanistically different, fully reversible option has had a genuine trial.
"Most concrete data" for the operation doesn't mean the medical options have been ruled out — it means they haven't been tried yet in this particular patient.
There's a way to get an answer faster than either path alone. The diagnostic spermatic cord block is low-risk and reversible, unlike the surgery, and it would tell us directly whether he's a plausible surgical responder — before he spends weeks on a gabapentinoid with real sedation and cognitive-dulling risk for a job where he's supervising a floor and operating equipment. Do the block now, and start a defined medical trial at the same time rather than choosing between them.
Agreed: proceed with a diagnostic spermatic cord block now, concurrent with starting low-dose nortriptyline for a defined six-week trial. Denervation is reserved for a clear block responder who does not improve on the medical trial.
Not agreed: how to weigh a partial-response picture at six weeks — a positive block plus some medical improvement — when deciding whether surgery is still warranted. Left for reassessment once both results are in.